Since July 2026, the European Union (EU) has shifted its focus from legislative reforms to practical applications, prioritizing supply-chain resilience, preventing medicine shortages, streamlining ...
Christy Owings, vice president and general manager of the Americas business unit at Thermo Fisher Scientific, discusses with ...
The IMA Pharmaceutical and MedTech divisions will be highlighting the TILE-X fill-finish line, a new VPHP BioIndicator, X-PEN autoinjector platform, and a range of machines from its IMA Active, IMA ...
David S. Thompson, CSAP, is Chief Alliance Officer at Eli Lilly and Company.
IMA Group announced that its Pharmaceutical and MedTech divisions will present their capabilities as an all-in-one supplier specializing in the design and manufacture of innovative machines and ...
In commercial tablet or capsule operations, validation helps protect the site’s ability to produce, release, and supply product without repeated disruption. This article discusses validation as a ...
Christy Owings, Thermo Fisher, speaks on why importer of record strategy and vetted local partners are key to reliable ...
Commercializing sustainability hinges on reframing it as risk mitigation and competitive advantage, supported by medium-to-long-term resilience planning and co-creation with suppliers rather than ...
Vice President and General Manager, Clinical Trials, Americas, at Thermo Fisher Scientific. With more than 20 years of ...
Christy Owings, Thermo Fisher, discusses how customs delays and import complexity risk clinical trial supply chains in Latin America. Christy Owings, Vice President and General Manager of the Americas ...
In a preview of their panel discussion at AAPS PharmSci 360 2026, Alfred Rumondor, PhD, AbbVie, and Swita Singh, PhD, Bristol ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results